Prosiectau (247)
Cardiff University Schools involved in this Project
Ca2+ oscillations and parthenogenetic development (03.10.2005 - 02.10.2009)
- Swann, Karl
Can alterations in cytokine signalling predict the onset of inflammatory arthritis (16.06.2012 - 15.01.2016)
- Jones, Simon
Cancer/ Bioinformatics PhD Studentship (01.04.2023 - 31.03.2026)
- Ager, Ann
Cancer/ Bioinformatics PhD Studentship (01.07.2023 - 30.09.2026)
- Eberl, Matthias
Cancer/ Bioinformatics PhD Studentship (01.10.2023 - 30.09.2026)
- Gallimore, Awen
Cancer exosomes as drivers of disease progression, targeting exosome biogenesis to halt disease progression (01.01.2014 - 31.12.2016)
- Clayton, Aled
Cancer exosomes control tumour reactive stroma in malignant pleural mesothelioma (01.11.2009 - 31.10.2010)
- Clayton, Aled
Cancer Genetics Biomedical Research Unit (31.03.2011 - 31.05.2015)
- Sampson, Julian
Cancer Genetics Service for Wales (01.02.2009 - 31.10.2012)
Cancer grand challenge – next generation T-cell therapies for childhood cancers (01.06.2022 - 31.05.2025)
- Sewell, Andrew
Cancer immunotherapy treatments (07.06.2017 - 17.06.2017)
- Tabi, Zsuzsanna
Cancer metastasis modelling platform (01.10.2015 - 30.09.2016)
- Jiang, Wen
Cancer Research Annual Meeting (01.01.2023 - 30.04.2023)
- Gallimore, Awen
Can microbiota modulate circadian oscillations to alter susceptibility to autoimmunity? (01.02.2020 - 31.10.2025)
- Pearson, James
Can modulating T-cell across inflamed endothelium prevent type 1 diabetes? (01.03.2012 - 28.02.2013)
- Wong, Susan
Cannabinoid therapy for Tuberous Sclerosis (01.08.2016 - 28.02.2017)
- Tee, Andrew
Cannabinoid therapy on tuberous sclerosis complex cell lines (01.10.2015 - 31.12.2015)
- Tee, Andrew
Can the annual screening interval for diabetic retinopathy be extended in patients with no retinopathy? (01.04.2008 - 31.03.2010)
Can we prevent generation of pro-thrombotic and pro-coagulant extracellular vesicle populations in blood via a simple dietary intervention? (01.10.2014 - 30.09.2017)
- Rees, Aled
Capecitabine, oxaliplatin then radiation then immediate curative surgery for operable rectal cancer (COPERNICUS) (01.04.2011 - 30.06.2015)
CAP-IT - Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia (CAP): A randomised trial (01.03.2016 - 31.05.2019)
- Powell, Colin
Cardiac microvascular function: Assessment and protection during coronary intervention (01.11.2011 - 30.04.2014)
Cardiff CTU wind down funding, 2023-2025 (01.10.2023 - 30.09.2025)
- Adams, Richard
Cardiff ECMC (01.04.2017 - 31.03.2023)
- Ottmann, Oliver
Cardiff EMC (01.04.2023 - 31.03.2028)
- Knapper, Steven
Cardiff Experimental Cancer Medicine Centre (01.04.2007 - 31.03.2012)
- Burnett, Alan
Cardiff Experimental Cancer Medicine Centre (01.04.2012 - 31.03.2017)
- Chester, John
Cardiff Molecular Genetics Research Application (01.05.2009 - 31.01.2016)
- Clarke, Angus
Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre (CREATE Centre) (01.07.2012 - 31.07.2017)
- Choy, Ernest
Cardiff University Infection and Immunity Annual meeting 2022 (01.09.2022 - 17.02.2023)
- Fielding, Ceri
Cardiovascular disease research (01.11.2013 - 31.10.2016)
- Williams, Alan
Cardiovascular Research Group Cymru (CvRG-C) (30.03.2010 - 31.03.2015)
Cardiovascular risk, alcohol-related harm and mental health: Total population pilot electronic record-linkage cohort study (01.10.2015 - 31.03.2016)
- Fone, David
Cardiovascular risk in patients with psoriatic and rheumatoid arthritis (01.09.2015 - 30.11.2017)
- Choy, Ernest
CARer-Administration of as-needed sub-cutaneous medication for breakthrough symptoms in home-based dying patients: A UK study (CARiAD) (01.11.2016 - 30.04.2019)
- Nelson, Annmarie
Cataract surgery: Measuring and predicting patient level vision related health benefits and harms (11.06.2017 - 24.06.2019)
Caveolin-1 a key predictor of treatment response to molecular targeted therapies in metastatic RCC (01.04.2011 - 31.03.2012)
- Griffiths, David
CD200: A putative target of AML (01.12.2008 - 30.11.2011)
- Tonks, Alex
CD59 as a modulator of human T cells (01.10.2008 - 01.08.2009)
- Gallimore, Awen
CD59 as a Modulator of T Cell Activity In Vivo (01.06.2006 - 30.09.2008)
- Gallimore, Awen
CD59 - A target to arrest age-related cartilage destruction in osteoarthritis (15.10.2010 - 14.10.2011)
- Williams, Anwen
CD8 coreceptor mediated optimization of the antigen specific T cell response (01.10.2012 - 31.08.2017)
- Price, David
Cell-based assay evaluation (01.06.2011 - 31.12.2012)
- Errington, Rachel
Cell biology of complement receptor 1 in Alzheimer's disease (01.01.2018 - 31.12.2020)
- Morgan, Paul
Cell-derived microparticles as mediators of obesity-induced vascular disease (03.08.2015 - 31.08.2017)
- Rees, Aled
Cell painting to patients - Developing novel bio-imaging tools for standardisation and reproducibility of AI-assisted image analysis (01.11.2022 - 31.03.2023)
- Parthimos, Dimitris
Cell-specific gene regulation in the developing human brain and genetic risk for neuropsychiatric disorders (01.11.2019 - 30.09.2022)
- Bray, Nicholas
Cell-specific genetic regulatory mechanisms mediating risk for neuropsychiatric disorders in the developing human brain (01.10.2023 - 31.03.2026)
- Bray, Nicholas
Cellular and molecular brain research (01.01.2021 - 31.12.2026)
- Hall, Jeremy
Cellular and viral immunology resource (23.04.2006 - 22.01.2010)
- Wang, Eddie
Cellular informatics - enabling the interoperability of cytometric data: A novel bioinformatics approach for revealing systems level understanding of cell cycle dynamics (01.04.2010 - 31.10.2012)
- Errington, Rachel
Cellular profiling and examination of alarmin signals in sepsis using CITE-seq (03.02.2020 - 02.10.2021)
Centre for Ageing and Dementia Research (CADR) (01.04.2015 - 31.03.2018)
- Williams, Julie
Centre for Ageing and Dementia Research (CADR) (01.04.2018 - 31.03.2020)
- Sims, Rebecca
Centre for E-health research for the improvement of population health (01.03.2013 - 28.02.2018)
- Paranjothy, Shantini
Centre for population health and wellbeing research (01.04.2015 - 31.03.2018)
- Paranjothy, Shantini
Centre for Population Health and Wellbeing Research (01.04.2018 - 31.03.2020)
- Choy, Ernest
Centre for Trials Research (01.04.2020 - 31.03.2023)
- Hood, Kerenza
Centre for trials research cancer group: Core funding QQR CTR and Haematology Clinical Trials Unit (01.10.2018 - 30.09.2024)
- Adams, Richard
Centre for Trials Research - Core infrastructure funding (01.03.2020 - 31.03.2023)
- Hood, Kerenza
Centre for trials research - core infrustructure funding (01.04.2023 - 31.03.2025)
- Hood, Kerenza
Centre for Trials Research - RCDS Component (01.03.2020 - 31.03.2023)
- Channon, Sue
Centre of Excellence in Adolescent Mental Health (01.10.2020 - 31.12.2026)
- Rice, Frances
CF PROSPER: Cystic Fibrosis Pregnancy Related Outcome data to Support PERsonal choices (01.10.2019 - 30.09.2021)
- Paranjothy, Shantini
Chair in healthcare improvement (01.11.2008 - 01.11.2011)
Chair of NCRI clinical and translational radiotherapy research working group (01.11.2008 - 31.10.2010)
Challenge Project: An innovative service Model for the end of life care of people with dementia (20.10.2014 - 31.03.2015)
- Noble, Simon
Change in alcohol outlet density and alcohol related harm to population health (01.07.2011 - 30.04.2014)
- Fone, David
Changing behaviour of health care officials and the general public towards a more prudent use of anti-microbial agents (CHAMP) (01.04.2007 - 31.03.2011)
Characterisation and role of phospholipids in the initiation of coagulation through tissue factor (01.08.2015 - 31.07.2018)
- Collins, Peter
Characterisation and targeting of the CD38 axix in chronic lymphocytic leukaemia (08.11.2010 - 30.11.2013)
- Pepper, Christopher
Characterisation of a novel class of natural killer cell immunoevasin (01.05.2021 - 28.02.2025)
- Wang, Eddie
Characterisation of biofilm ultrastructure: Investigation and methods for developing strategies for control and prevention of infections (01.10.2009 - 31.03.2016)
- Hobot, Jan
Characterisation of epitope-specific autoimmune responses (01.08.2013 - 30.11.2016)
- Wong, Susan
Characterisation of gene regulation changes in human CHD8 mutant iPSCs during neural differentiation and relevance to Autism Spectrum Disorder (01.02.2020 - 01.06.2022)
- Williams, Hywel
Characterisation of HPV infection in young women attending first cervical cancer screening (01.03.2009 - 30.11.2011)
Characterisation of novel endogenous lipid mediators of cardiovascular function and disease (20.05.2013 - 31.08.2018)
- O'Donnell, Valerie
Characterisation of platelet and microparticle phospholipids in thrombotic and bleeding disorders (01.08.2016 - 31.10.2019)
- Collins, Peter
Characterisation of positive and negative influences in tumour immunity (01.06.2009 - 31.07.2012)
- Gallimore, Awen
Characterisation of the effects of spermidine, a nutrition supplement, on the immune memory response to Coronavirus vaccine in older people - a feasibility study (08.12.2021 - 31.12.2025)
- Spiller, Brad
Characterisation of the functional role of CD38 in chronic lymphocytic leukaemia by lentiviral infection of primary leukaemic cells 1 (01.01.2008 - 31.03.2011)
- Brennan, Paul
Characterisation of the functional role of CD38 in chronic lymphocytic leukaemia by lentiviral infection of primary leukaemic cells 2 (01.05.2008 - 30.04.2011)
- Brennan, Paul
Characterisation of the immune stimulatory component of honey (01.04.2008 - 31.03.2009)
- Tonks, Mandy
Characterisation of the molecular mechanisms underlying ryanodine receptor dysfunction in stress-induced ventricular tachycardia (01.10.2004 - 30.09.2009)
- George, Christopher
Characterisation of the neural basis underlaying appetitive extinction in a model of psychosis disorders (01.10.2020 - 31.12.2020)
- Hall, Jeremy
Characterisation of the role of osteocyte-derived microparticles in health and disease (01.04.2015 - 31.07.2016)
- Evans, Bronwen
Characterising exosome uptake for elucidating their role in cancer progression and as potential drug delivery vectors (01.10.2015 - 01.12.2018)
- Clayton, Aled
Characterising Genetic Modifiers of Huntington's Disease (01.10.2021 - 30.04.2024)
- Jones, Aileen Lesley
Characterising the behavioural and neural functions of steroid sulfatase, a newly-identified modulator of ADHD risk (15.03.2010 - 14.03.2013)
- Davies, William
Characterising the function of the schizophrenia susceptibility gene ZNF804A (01.01.2010 - 30.06.2012)
- O'Donovan, Michael
Characterising the nature of primary care patient safety incident reports in England and Wales: Mixed method study (01.12.2013 - 31.05.2016)
- Carson-Stevens, Andrew
Characterising the role of exosomes in Tuberous Sclerosis complex (01.10.2018 - 31.01.2022)
- Dunlop, Elaine
Characterising the role of oxidized lipids in the mechanism of epidermal barrier information (01.07.2013 - 30.09.2014)
- O'Donnell, Valerie
Characterising the tumour suppressor function of folliculin (01.10.2008 - 30.09.2011)
- Tee, Andrew
Characterization and optimization of T cell/antigen interactions (01.01.2009 - 31.12.2012)
- Sewell, Andrew
Characterize antibodies to determine their function and affinity (01.11.2007 - 30.09.2009)
- Morgan, Paul
Characterizing the signalling mechanism of the mTOR-dependant phosphatase (01.09.2007 - 31.08.2010)
- Tee, Andrew
Chemical biological and therapeutic actions of esterified eicosanoids generated by human immune cells: Understanding membrane signalling actions of novel lipid families (01.08.2011 - 31.12.2017)
- O'Donnell, Valerie
Chemiluminescent nanofibre-based POC device for predicitng of risk Type 2 diabetes (01.04.2014 - 30.11.2014)
- Weeks, Ian
Chemotherapy then radiation then immediate curative surgery for operable rectal cancer (COPERNICUS) (01.12.2011 - 31.12.2015)
- Hurt, Christopher